Skip to main content
Clinical Trials/CTRI/2023/04/051934
CTRI/2023/04/051934
Not Applicable
Phase 4

Combined Platelet Rich Plasma and Amniotic Membrane Graft Versus Amniotic Membrane Graft Alone for Treatment of infectious Perforated Central Corneal Ulcer.

Faculty of Medicine zagzaig university hospitals0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: H160- Corneal ulcer
Sponsor
Faculty of Medicine zagzaig university hospitals
Status
Not Applicable
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Faculty of Medicine zagzaig university hospitals

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients aged above 18 years old.
  • 2\. Perforated corneal ulcer following infectious keratitis
  • either bacterial, fungal, viral or acanthamoeba keratitis as
  • evidenced by positive Seidel testing.
  • 3\. Corneal perforation 2\-4 mm size.

Exclusion Criteria

  • 1\. Evidence of intraocular infection by B\-scan ultrasound.
  • 2\. Perforated corneal ulcer or impending perforation after noninfectious keratitis either traumatic, immune or chronic
  • 3\. Perforation more than 4 mm size or less than 2 mm size.
  • 4\. Patients with NO PL visual acuity.
  • 5\. Iris or lens tissue prolapse.
  • 6\. Contraindications for Platelet Rich Plasma e.g. (platelet
  • dysfunction syndrome, critical thrombocytopenia,
  • hemodynamic instability and septicemia).
  • 7\. Contraindications for AMG e.g. (severe dry eye,
  • lagophthalmos and severe necrosis caused by ischemia).

Outcomes

Primary Outcomes

Not specified

Similar Trials